Intrauterine Devices, Copper
"Intrauterine Devices, Copper" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Intrauterine contraceptive devices that depend on the release of metallic copper.
Descriptor ID |
D007435
|
MeSH Number(s) |
E07.190.250.510.520.300
|
Concept/Terms |
Intrauterine Devices, Copper- Intrauterine Devices, Copper
- Copper Intrauterine Device
- Device, Copper Intrauterine
- Devices, Copper Intrauterine
- Intrauterine Device, Copper
- Copper-Releasing IUDs
- Copper-Releasing IUD
- IUD, Copper-Releasing
- IUDs, Copper-Releasing
- IUD, Copper Releasing
- Copper Releasing IUD
- Copper Intrauterine Devices
|
Below are MeSH descriptors whose meaning is more general than "Intrauterine Devices, Copper".
Below are MeSH descriptors whose meaning is more specific than "Intrauterine Devices, Copper".
This graph shows the total number of publications written about "Intrauterine Devices, Copper" by people in this website by year, and whether "Intrauterine Devices, Copper" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2010 | 1 | 0 | 1 |
2016 | 1 | 0 | 1 |
2017 | 0 | 1 | 1 |
2020 | 2 | 0 | 2 |
2021 | 3 | 0 | 3 |
2023 | 1 | 0 | 1 |
2024 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Intrauterine Devices, Copper" by people in Profiles.
-
Sexual behaviour among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: Data from the ECHO randomized trial. PLoS One. 2024; 19(5):e0299802.
-
Effects of depot medroxyprogesterone acetate, the copper IUD and the levonorgestrel implant on testosterone, sex hormone binding globulin and free testosterone levels: ancillary study of the ECHO randomized clinical trial. BMC Womens Health. 2024 Mar 08; 24(1):167.
-
Contraceptive Continuation and Experiences Obtaining Implant and IUD Removal Among Women Randomized to Use Injectable Contraception, Levonorgestrel Implant, and Copper IUD in South Africa and Zambia. Stud Fam Plann. 2023 06; 54(2):379-401.
-
Contraceptive method preference and reasons for contraceptive discontinuation among women randomized to intramuscular depot medroxyprogesterone acetate, a copper intrauterine device or a levonorgestrel implant: Findings from Durban, South Africa. Contraception. 2022 04; 108:37-43.
-
Behavioral effects of different contraceptive methods and HIV acquisition: an ancillary study of the ECHO randomized trial. Reprod Health. 2021 Sep 29; 18(1):192.
-
Effects of three contraceptive methods on depression and sexual function: An ancillary study of the ECHO randomized trial. Int J Gynaecol Obstet. 2021 Aug; 154(2):256-262.
-
Sexually transmitted infections among women randomised to depot medroxyprogesterone acetate, a copper intrauterine device or a levonorgestrel implant. Sex Transm Infect. 2021 06; 97(4):249-255.
-
Effects of Depot Medroxyprogesterone Acetate, Copper Intrauterine Devices, and Levonorgestrel Implants on Early HIV Disease Progression. AIDS Res Hum Retroviruses. 2020 08; 36(8):632-640.
-
Psychological, behavioural and physiological effects of three long-acting reversible contraception (LARC) methods: protocol for an ancillary study of the ECHO randomised trial. BMJ Open. 2017 Nov 12; 7(11):e019205.
-
Effects of the copper intrauterine device versus injectable progestin contraception on pregnancy rates and method discontinuation among women attending termination of pregnancy services in South Africa: a pragmatic randomized controlled trial. Reprod Health. 2016 Apr 18; 13:42.